Physician profile
Aaron M King
NPI 1528001187
$2,404.58
in general payments reported to CMS, 2019-2025
19 companies · $514 in 2025
The $514 reported for 2025 was more than what 94% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $168 · 2020: $56.58 · 2021: $236 · 2022: $796 · 2023: $439 · 2024: $195 · 2025: $514.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,147.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,147.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biomerieux INC | $610.87 | 2022 | |
| Pfizer INC. | $546.10 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $262.69 | 2019-2025 | Vaxneuvance, Vaxelis, Gardasil 9 |
| Sanofi Pasteur INC. | $174.47 | 2019-2024 | |
| Novo Nordisk INC | $174.18 | 2022-2023 | Rybelsus |
| Kaleo, INC. | $108.69 | 2019-2022 | |
| Cranial Technologies, INC | $95.35 | 2019-2025 | Doc Band |
| Sobi, INC | $70.52 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $67.51 | 2024 | |
| Alk-Abello, INC | $44.91 | 2025 | Neffy |
| Collegium Pharmaceutical, INC. | $43.89 | 2025 | Jornay Pm |
| Seqirus USA INC | $40.51 | 2025 | Flucelvax |
| Sanofi-Aventis U.S. LLC | $31.97 | 2025 | |
| Ars Pharmaceuticals Operations, INC. | $26.96 | 2025 | Neffy |
| Kyowa Kirin, INC. | $25.99 | 2025 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Verrica Pharmaceuticals INC. | $25.00 | 2023 | Ycanth |
| Genentech USA, INC. | $18.77 | 2021 | |
| Biomarin Pharmaceutical INC. | $18.19 | 2024 | Voxzogo 1.2mg |
| Kowa Pharmaceuticals America, INC. | $18.01 | 2025 | Zoryve |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aaron King listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.